- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB announces outcome in rights issue of units | 105 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA... ► Artikel lesen | |
| 18.08. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB Enters into Top-down Guarantee Agreement in Ongoing Rights Issue of Units | 168 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA... ► Artikel lesen | |
| 13.08. | Clinical Laserthermia Systems AB: Last Day of Subscription in Clinical Laserthermia Systems AB' Rights Issue of Units is 18 August 2026 | 1 | Cision News | ||
| 06.08. | Clinical Laserthermia Systems AB: Majority of CLS Board and Key Executive Management Commit to Invest in the Company's Rights Issue | 158 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today announces that a majority of the members of its Board of Directors, together with key members of executive management, have entered... ► Artikel lesen | |
| 04.08. | Clinical Laserthermia Systems AB: The Subscription Period in Clinical Laserthermia Systems AB' Rights Issue of Units Begins Today | 2 | Cision News | ||
| 29.07. | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.07.2026 | 284 | Xetra Newsboard | Das Instrument D7X AU000000DMG9 DRAGON MOUNTAIN GOLD LTD EQUITY wird cum Kapitalmassnahme gehandelt am 29.07.2026 und ex Kapitalmassnahme am 30.07.2026 The instrument D7X AU000000DMG9 DRAGON MOUNTAIN... ► Artikel lesen | |
| CLINICAL LASERTHERMIA SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 23.07. | Clinical Laserthermia Systems AB: Board of Directors of Clinical Laserthermia Systems AB resolves on a rights issue of units of initially approximately SEK 39.5 million | 449 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, RUSSIA... ► Artikel lesen | |
| 17.07. | Clinical Laserthermia Systems AB: CLS Publishes Half-year Report January - June 2026 | 344 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its half-year report for January - June 2026. The report is published earlier than previously communicated... ► Artikel lesen | |
| 29.06. | Clinical Laserthermia Systems AB: Communique from the Annual General Meeting on Monday June 29th in Clinical Laserthermia Systems AB | 174 | GlobeNewswire (Europe) | Today, June 29th, 2026 the Annual General Meeting (the "AGM") of Clinical Laserthermia Systems AB, 556705-8903, was held. Below is a summary of the decisions taken. All decisions were taken with the... ► Artikel lesen | |
| 04.06. | Clinical Laserthermia Systems publishes annual report for 2025 | 1 | Cision News | ||
| 28.05. | Clinical Laserthermia Systems AB: Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 29, 2026 | 2 | Cision News | ||
| 12.05. | Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - March 2026 | 272 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - March 2026.Highlights of First Quarter Interim Report 2026
During the... ► Artikel lesen | |
| 28.04. | Clinical Laserthermia Systems AB: CLS Strengthens its Strategic Partnership in Neurosurgery and Aims to Become Market Leader in Neuro LITT | 257 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (CLS) today announced it has reached an agreement with its strategic partner on an alignment to accelerate the growth of the ClearPoint Prism® business. The plan includes... ► Artikel lesen | |
| 20.02. | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems AB publishes Year-end report January - December 2025 | 391 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its Year-end report for January - December 2025.Highlights of the Year-end report 2025The year 2025 represents... ► Artikel lesen | |
| 12.12.25 | Clinical Laserthermia Systems AB: CLS initiates recruitment process for permanent Chief Financial Officer | 323 | GlobeNewswire (Europe) | Clinical Laserthermia Systems AB (publ) ("CLS") today announces that the company has decided to transition from its current interim, part-time consulting CFO arrangement to a permanent and fully employed... ► Artikel lesen | |
| 14.11.25 | Clinical Laserthermia Systems AB: CLS Publishes Interim Report January - September 2025 | 997 | GlobeNewswire (Europe) | Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - September 2025.Highlights of the Third Quarter Interim ReportDuring the... ► Artikel lesen | |
| 07.10.25 | Clinical Laserthermia Systems AB: CLS-sponsored neuro LITT study in patients with malignant brain tumor shows positive results | 254 | GlobeNewswire (Europe) | Lund, Sweden, October 7th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS") today announces positive results from a clinical safety study on laser ablation, performed using CLS proprietary LITT... ► Artikel lesen | |
| 04.09.25 | Clinical Laserthermia Systems AB: Clinical Laserthermia Systems Receives FDA Clearance for Expanded Labeling of the ClearPoint Prism[] Neuro Laser Therapy System, doubling the addressable U.S market for Neuro LITT | 404 | GlobeNewswire (Europe) | Lund, Sweden - September 4th, 2025 - Clinical Laserthermia Systems AB (publ) ("CLS" or "the Company") today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for expansion... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,345 | +1,09 % | Fresenius macht weitere 300 Millionen Euro bei FMC zu Geld | Fresenius trennt sich von weiteren 7,8 Millionen Aktien der Fresenius Medical Care (FMC) und erlöst damit rund 300 Millionen Euro. Das Paket entspricht etwa 2,9 Prozent des ausgegebenen FMC-Grundkapitals... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,280 | -2,00 % | BERENBERG stuft CARL ZEISS MEDITEC AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28 Euro auf "Hold" belassen. Der neue Chef der Jenaer müsse einiges auf dem Schirm... ► Artikel lesen | |
| INTUITIVE SURGICAL | 317,50 | -0,27 % | Intuitive Surgical: Exzellentes Geschäftsmodell, aber ist die Aktie jetzt zu teuer? | Intuitive Surgical gilt als Qualitätsunternehmen mit dominierender Marktstellung in der roboterassistierten Chirurgie, doch die aktuelle Bewertung der Aktie erscheint angesichts der jüngsten Kennzahlen... ► Artikel lesen | |
| DRAEGERWERK | 112,20 | +0,90 % | dpa-AFX-Überblick: UNTERNEHMEN vom 10.08.2026 - 15.15 Uhr | ROUNDUP: Hypoport bestätigt Jahresziele für 2026 - Aktie legt zu BERLIN - Der Finanzdienstleister Hypoport sieht sich auf Kurs zu seinen Jahreszielen. "Die geopolitischen Spannungen des ersten Halbjahres... ► Artikel lesen | |
| MEDTRONIC | 79,04 | +1,26 % | Medtronic: Optionsmarkt rechnet mit 4 % Kursbewegung nach Quartalszahlen | ||
| THERMO FISHER | 543,40 | +1,00 % | Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside? | ||
| TELADOC HEALTH | 5,392 | +1,62 % | BetterHelp Has the Demand: Can Teladoc Build the Capacity? | ||
| HIMS & HERS HEALTH | 25,680 | -5,59 % | Aktien New York: Chipwerte belasten Nasdaq - US-Pläne gegen Iran bewegen kaum | NEW YORK (dpa-AFX) - Technologieaktien haben am Montag in den USA erneut geschwächelt. Standardwerte legten dagegen überwiegend moderat zu. Negative Vorgaben aus Asien, die am Mittwoch nachbörslich... ► Artikel lesen | |
| M1 AESTHETICS | 12,700 | -0,78 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,065 | -6,07 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| ALCON | 62,52 | -0,60 % | UV-Schutz reicht nicht mehr? Warum die nächste Generation von Brillengläsern für EssilorLuxottica, Alcon & Co. zum Technologiethema wird | ||
| DEXCOM | 76,40 | 0,00 % | Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now? | ||
| RESMED | 200,00 | -1,28 % | ResMed Stock: Analyst Estimates & Ratings | ||
| HEALWELL AI | 0,479 | +1,05 % | HEALWELL AI: HEALWELL AI's DARWEN AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation | Pentavere advances from winning the 2024 Prix Galien USA Award to competing internationally among Prix Galien winners from around the world, further validating DARWEN AI as a globally recognized... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,260 | -1,11 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen |
Das Unternehmen CLINICAL LASERTHERMIA SYSTEMS AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,118 Euro und damit +0,85 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLINICAL LASERTHERMIA SYSTEMS AB finden Sie auf Wallstreet Online.